ESR1 and triple-negative breast carcinoma: One subgroup with a particularly poor prognosis are triple-negative breast carcinomas (TNBCs) characterized by lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression.